How do peptides work?
How do peptides work? These mechanism articles are the how behind the what. If you want to understand what a GLP-1 dual agonist actually does after injection, why a growth hormone peptide works with your pituitary instead of around it, or which receptor a molecule binds — this is that shelf.
Written to be understood like you're fifteen, sourced from the primary literature, and honest wherever the mechanism is still a hypothesis rather than settled science.
147 articles on this topic
-

Tesamorelin 10 mg: What the Vial Number Means
A tesamorelin 10 mg label describes the total peptide in the vial, not the amount in one injection. The prescribed amount, liquid volume, and days of supply come from the pharmacy label and provider's plan.
-

Tirzepatide Before and After: An Honest Timeline
Tirzepatide before and after photos can't tell you what caused a change. The trials give a more useful timeline: early appetite shifts, months of gradual change, and a later plateau that varies widely.
-

SS-31 and MOTS-c: Can You Take Them Together?
They are both mitochondrial peptides, and that is about where the similarity stops. No published trial has given people both at once — here is what each one has behind it.
-

When to Take MOTS-c: What Human Research Says
No human trial has shown that morning, night, or a workout window is best. The exercise link is real but easy to overread: researchers measured the MOTS-c people made themselves, not the effect of a timed dose.
-

Kisspeptin-54 vs Kisspeptin-10: Why Length Matters
Kisspeptin-54 is the whole peptide; kisspeptin-10 is its last ten amino acids. The long one lasts about seven times longer in the blood, and that one fact explains which studies used which.
-

Sermorelin for Muscle Growth: Evidence Is Limited
Sermorelin can raise growth-hormone pulses, but that does not automatically build muscle. The human studies are small, and they have not shown a reliable strength benefit.
-

What Is Cagrilintide? The Amylin Half of CagriSema
Cagrilintide is an experimental copy of the appetite hormone amylin, and the other half of Novo Nordisk's CagriSema. It is not approved, it is not sold here, and a US decision is expected before the end of 2026.
-

GHK-Cu Studies Find a Gap in Human Evidence
A new systematic review found only two randomized human GHK-Cu trials among 20 eligible studies, and both were topical. The injectable claims run well ahead of the clinical evidence.
-

Is Sermorelin a Steroid? No, It Is a Peptide
Sermorelin is a peptide signal that asks the pituitary to release growth hormone. It is neither an anabolic steroid nor HGH itself, though sports drug-testing rules still matter.
-

Kisspeptin for Women: What the Research Shows
Kisspeptin has been given to women in a handful of small hospital trials — to mature eggs during IVF, to restart stalled hormone signalling, and once to watch the brain respond to sexual cues. Here is what those studies found, and what they did not.
-

TB-500 Half-Life: The Honest Answer Is Unknown
There is no reliable human half-life for the TB-500 fragment. The familiar one-to-two-hour estimate comes from the 44-amino-acid recombinant study molecule NL005, tested by a different route.
-

Tesamorelin Cycle: Why Doctors Talk About Duration
There is no on-and-off tesamorelin cycle in the research. The trials ran it daily for 26 weeks and then 52 — and when people stopped, the visceral fat came back.
-

CJC-1295 Ipamorelin for Muscle Growth: No Trial
These peptides can raise signals along the growth hormone pathway, but no human trial has shown that the pair builds muscle or increases strength. The honest case is a plausible mechanism, not a bodybuilding result.
-

Kisspeptin and Testosterone: Pattern Beats Amount
A study published on August 3, 2026 gave 15 healthy men kisspeptin-10 three different ways. Five days of it around the clock and the pituitary stopped answering; eight hours on and sixteen off, and it kept answering for twelve days.
-

MOTS-c Half-Life: What Is Actually Known
No published study has measured how long the body takes to clear a dose of MOTS-c. Here is what the rodent work, the exercise data and one unpublished Phase 1 trial actually show.
-

Selank for Anxiety: What the Research Shows
Three small Russian trials, 192 patients, and no placebo arm between them. Here is what that evidence supports, what it doesn't, and where US regulators have landed.
-

Sermorelin Nasal Spray: What Gets Past Your Nose
The one study that measured it found about 3 to 5 percent of a nasal dose reached the bloodstream. That number, and what happened when researchers kept spraying for six months, is most of the story.
-

What Is Tesamorelin Used For?
Tesamorelin has one narrow labeled use: reducing excess abdominal fat in adults with HIV-associated lipodystrophy. Uses beyond that label need a more careful answer.
-

Kisspeptin Benefits: What Human Studies Found
In people, kisspeptin has done two things reliably: switched on the reproductive hormone system, and changed how the brain handles sexual cues. Nearly all of it was measured over hours, in a hospital.
-

KLOW Peptide Stack: Four Peptides in One Vial
A “stack” just means taking more than one peptide at a time. KLOW is one that comes already mixed — four peptides in a single prescribed vial, so there is nothing for you to assemble.
Page 3 of 8 · 147 articles